

Day 1 9/19
Hitting Our STRIDE: Integrating Dual Immunotherapy with Locoregional Therapy in HCC
Beyond Boundaries: The Evolving Landscape and Future of HER2 ADCs Across Tumor Types
Updated Treatment Strategy for Advanced Urothelial Carcinoma
Treatment Strategy for mRCC: What Can We Learn from Real World Experience?